This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mortimer, J. A. Articles by Snowdon, D. A. Search for Related Content PubMed PubMed Citation Articles by Mortimer, J. A. Articles by Snowdon, D. A. Pubmed/NCBI databases Medline Plus Health Information Alzheimer's Disease Social Bookmarking                   What's this?

Very Early Detection of Alzheimer Neuropathology and the Role of Brain Reserve in Modifying Its Clinical Expression

Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL, jmortime{at}hsc.usf.edu

Amy R. Borenstein, PhD

Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL

Karen M. Gosche, PhD

NeuroImaging Research, Alachua, FL

David A. Snowdon, PhD

Sanders-Brown Center on Aging and Department of Neurology, University of Kentucky, Lexington, KY

Numerous studies show that the pathology of Alzheimer’s disease is present decades before a clinical diagnosis of dementia can be made. Given the likelihood that agents will become available that reliably delay onset and/or slow progression of Alzheimer’s disease, it will be important to detect preclinical Alzheimer’s disease as early as possible for maximal treatment effect. Detection of individuals by sensitive cognitive measures provides one way to identify people who are at high risk of developing clinical Alzheimer’s disease. However, it is likely that those with considerable brain or cognitive reserve will be able to mask cognitive deficits until very close to the onset of the dementia, rendering such cognitive measures insensitive. Optimum biomarkers for Alzheimer’s disease therefore need to target the severity of underlying brain pathology independently of brain reserve. Findings are presented showing the importance of higher education and larger brain size in masking the underlying disease pathology.

Key Words: Alzheimer’s disease • biomarkers • prevention

Journal of Geriatric Psychiatry and Neurology, Vol. 18, No. 4, 218-223 (2005)
DOI: 10.1177/0891988705281869


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Peters, N. Beckett, M. Geneva, M. Tzekova, F. H. Lu, R. Poulter, N. Gainsborough, B. Williams, M.-C. de Vernejoul, A. Fletcher, et al. Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVET Age Ageing, June 24, 2009; (2009) afp094v1. [Abstract] [Full Text] [PDF]

				O. Querbes, F. Aubry, J. Pariente, J.-A. Lotterie, J.-F. Demonet, V. Duret, M. Puel, I. Berry, J.-C. Fort, P. Celsis, et al. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve Brain, May 12, 2009; (2009) awp105v1. [Abstract] [Full Text] [PDF]

				R. Duara, D. A. Loewenstein, E. Potter, J. Appel, M. T. Greig, R. Urs, Q. Shen, A. Raj, B. Small, W. Barker, et al. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease Neurology, December 9, 2008; 71(24): 1986 - 1992. [Abstract] [Full Text] [PDF]

				C. M. Roe, M. A. Mintun, G. D'Angelo, C. Xiong, E. A. Grant, and J. C. Morris Alzheimer Disease and Cognitive Reserve: Variation of Education Effect With Carbon 11-Labeled Pittsburgh Compound B Uptake Arch Neurol, November 1, 2008; 65(11): 1467 - 1471. [Abstract] [Full Text] [PDF]

				M. Scazufca, P. R Menezes, R. Araya, V. D Di Rienzo, O. P Almeida, D. Gunnell, and D. A Lawlor Risk factors across the life course and dementia in a Brazilian population: results from the Sao Paulo Ageing & Health Study (SPAH) Int. J. Epidemiol., August 1, 2008; 37(4): 879 - 890. [Abstract] [Full Text] [PDF]

				M. L. Bleecker, D. P. Ford, M. A. Celio, C. G. Vaughan, and K. N. Lindgren Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance Neurology, July 31, 2007; 69(5): 470 - 476. [Abstract] [Full Text] [PDF]

				C. M. Roe, C. Xiong, J. P. Miller, and J. C. Morris Education and Alzheimer disease without dementia: Support for the cognitive reserve hypothesis Neurology, January 16, 2007; 68(3): 223 - 228. [Abstract] [Full Text] [PDF]

				D. A. Bennett, J. A. Schneider, Z. Arvanitakis, J. F. Kelly, N. T. Aggarwal, R. C. Shah, and R. S. Wilson Neuropathology of older persons without cognitive impairment from two community-based studies Neurology, June 27, 2006; 66(12): 1837 - 1844. [Abstract] [Full Text] [PDF]

				L. F. Jarvik and D. Blazer Children of Alzheimer Patients: An Overview J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 181 - 186. [PDF]

				L. Ercoli, P. Siddarth, T. Harrison, E. Jimenez, and L. F. Jarvik Similar Neurocognitive Performance of Adults With and Without a History of Parental Alzheimer's Disease: A Pilot Study J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 208 - 212. [Abstract] [PDF]